Keywords: visiongain, migraine, ibs, market, reports, new, report

Visiongain migraine and IBS market reports

Article | 01 March 2004

Print This

A new report by international analysts Visiongain is forecasting that the global anti-migraine drug market will double its value from $2.7 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in